Get the Daily Brief
Latest Biotech News
Advances in Cancer Diagnostics and Therapeutics Leverage AI, Spatial Proteomics, and Gene Editing
Recent studies reveal transformative innovations in oncology diagnostics and treatment modalities. AI-driven radiomics and multi-modal models are enhancing detection and prognosis in pancreatic,...
Breakthroughs in Neuroscience and Neurodegeneration: Autoimmunity and Imaging Advances
Groundbreaking research links neurodegenerative diseases such as ALS and Parkinson’s to autoimmune processes involving T cell responses to neuronal proteins like C9orf72. Novel imaging techniques,...
Novel Biotechnologies Propel Regenerative Medicine and Stem Cell Research
Recent studies have expanded capabilities in stem cell biology and regenerative medicine. USC researchers have successfully cultured authentic embryonic stem cells from multiple bird species using...
AI and Digital Technologies Enhance Drug Discovery and Clinical Trials
The integration of artificial intelligence and digital platforms is accelerating drug discovery and clinical research. Pharma companies are pooling proprietary structural data for training large...
FDA and Regulatory Developments Impact U.S. Biopharmaceutical Industry
Regulatory agencies face operational challenges due to government funding uncertainties, affecting drug submissions and approvals. The FDA is suspending acceptance of new drug submissions amid a...
Enzyme Applications Drive Innovation Across Biotech and Industrial Sectors
Enzymes continue to transform biotechnology and industrial processes through sustainable, efficient biocatalysis. Their role extends beyond food and beverage, impacting textiles, pharmaceuticals,...
Takeda Exits Cell Therapy Amid Financial Restructuring
Takeda Pharmaceutical has announced the complete discontinuation of its cell therapy research and development efforts, including layoffs of 137 employees in Massachusetts. The decision follows a...
Novartis Wins FDA Nod for Oral BTK Inhibitor in Chronic Hives
The U.S. Food and Drug Administration approved Novartis's oral Bruton’s tyrosine kinase inhibitor, remibrutinib (branded as Rhapsido), as a second-line treatment for chronic spontaneous urticaria...
Pfizer and Trump Administration Strike Most-Favored Nation Drug Pricing Deal
Pfizer has become the first pharmaceutical company to agree to the Trump administration's most-favored nation pricing initiative, committing to sell select medicines in the United States at prices...
AI Advances Propel Cancer Imaging and Diagnostics
Artificial intelligence technologies are demonstrating significant breakthroughs in oncology, ranging from automated segmentation and prediction of metastatic spread using imaging, to the...
Breakthroughs in Spatial Proteomics and Multi-Omics Analysis
Researchers have developed cutting-edge software and techniques enhancing analysis of spatial multiomics data, a pivotal advance for understanding tissue microenvironments and disease mechanisms...
Gene Editing and DNA Synthesis Innovations Spur Biotech Growth
Advances in gene editing and DNA synthesis technologies are accelerating biotech innovation. Companies are pursuing novel editing platforms that improve precision and extend beyond CRISPR, while...
Cancer Research and Therapeutics: New Targets and Treatment Approaches
Recent studies uncover novel molecular targets and therapeutic strategies for various cancers. From exploiting immune mechanisms to silence oncogenic pathways to pairing chemotherapy with...
Innovations in Battery Technology and Sustainable Energy
Researchers are making significant strides in battery technology to meet growing energy demands sustainably. Advances include improved lithium–sulfur battery charge retention via new filtration...
Emerging Roles of AI and Digital Tools in Biotech and Healthcare
Artificial intelligence and digital innovations are increasingly embedded in biotech and healthcare, enhancing research, diagnostics, and patient care. Platforms utilizing AI streamline clinical...
Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer Pipeline
Danish biotech Genmab has agreed to acquire Netherlands-based Merus for approximately $8 billion. The acquisition centers on Merus’ lead asset petosemtamab, an EGFRxLGR5 bispecific antibody with...
Novartis Gains FDA Approval for First Oral BTK Inhibitor in Chronic Hives
Novartis received FDA approval for Rhapsido (remibrutinib), the first oral Bruton’s tyrosine kinase (BTK) inhibitor indicated as a second-line treatment for chronic spontaneous urticaria (CSU)....
Takeda Halts Cell Therapy Research as Part of Strategic Portfolio Shift
Japanese pharmaceutical giant Takeda announced it will discontinue all cell therapy research and development activities, including platform technologies and clinic-ready programs without active...
AI and Digital Technologies Advance Biopharma Manufacturing and Drug Discovery
Biopharma companies are intensifying adoption of digital transformation and AI to enhance manufacturing efficiency and drug discovery. Experts caution the need for critical education to prevent AI...
FDA Actions Impacting Rare Disease and Pediatric Drug Approvals
The FDA issued a complete response letter rejecting the NDA for CUTX-101, a copper replacement therapy for rare pediatric Menkes disease, citing manufacturing facility deficiencies. This setback...